Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Kantor

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Visualized Experiments : Jove|December 30, 2017
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing CellsSriram Vijayraghavan, Boris Kantor
Viruses|August 10, 2021
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and PerspectivesWendy Dong, Boris Kantor
Progress in Molecular and Subcellular Biology|May 11, 2005
DNA methylation in epigenetic control of gene expressionAharon Razin, Boris Kantor
International Journal of Molecular Sciences|January 30, 2021
<i>APOE</i>: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer'sAnna Yang, Boris Kantor, Ornit Chiba-Falek
STAR Protocols|December 30, 2020
An Improved Protocol for the Production of Lentiviral VectorsLogan Y Brown, Wendy Dong, Boris Kantor
Molecular Therapy. Nucleic Acids|January 7, 2026
CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challengesBoris Kantor, Leanne Duke, Pradeep G Bhide
Molecular Therapy. Nucleic Acids|August 13, 2025
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative diseaseBoris Kantor, Bernadette O'Donovan, Ornit Chiba-Falek
Molecular Therapy. Nucleic Acids|December 22, 2023
Neuronal-type-specific epigenome editing to decrease <i>SNCA</i> expression: Implications for precision medicine in synucleinopathiesZhiguo Sun, Boris Kantor, Ornit Chiba-Falek
Frontiers in Bioengineering and Biotechnology|November 3, 2022
Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugsJoseph Rittiner, Mohanapriya Cumaran, Sahil Malhotra, et al.
Gene Expression Patterns : GEP|December 4, 2003
Expression and localization of components of the histone deacetylases multiprotein repressory complexes in the mouse preimplantation embryoBoris Kantor, Kirill Makedonski, Ruth Shemer, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Visualized Experiments : Jove|December 30, 2017
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing CellsSriram Vijayraghavan, Boris Kantor
Viruses|August 10, 2021
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and PerspectivesWendy Dong, Boris Kantor
Progress in Molecular and Subcellular Biology|May 11, 2005
DNA methylation in epigenetic control of gene expressionAharon Razin, Boris Kantor
International Journal of Molecular Sciences|January 30, 2021
<i>APOE</i>: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer'sAnna Yang, Boris Kantor, Ornit Chiba-Falek
STAR Protocols|December 30, 2020
An Improved Protocol for the Production of Lentiviral VectorsLogan Y Brown, Wendy Dong, Boris Kantor
Molecular Therapy. Nucleic Acids|January 7, 2026
CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challengesBoris Kantor, Leanne Duke, Pradeep G Bhide
Molecular Therapy. Nucleic Acids|August 13, 2025
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative diseaseBoris Kantor, Bernadette O'Donovan, Ornit Chiba-Falek
Molecular Therapy. Nucleic Acids|December 22, 2023
Neuronal-type-specific epigenome editing to decrease <i>SNCA</i> expression: Implications for precision medicine in synucleinopathiesZhiguo Sun, Boris Kantor, Ornit Chiba-Falek
Frontiers in Bioengineering and Biotechnology|November 3, 2022
Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugsJoseph Rittiner, Mohanapriya Cumaran, Sahil Malhotra, et al.
Gene Expression Patterns : GEP|December 4, 2003
Expression and localization of components of the histone deacetylases multiprotein repressory complexes in the mouse preimplantation embryoBoris Kantor, Kirill Makedonski, Ruth Shemer, et al.
Pageof 4